Results 221 to 230 of about 42,053 (270)
Some of the next articles are maybe not open access.
Drugs, 1988
While controversy still exists as to the precise indications for the treatment of all forms of ventricular arrhythmia, advances in the number and, more importantly, type of antiarrhythmic drugs can provide the clinician with a rational basis for selecting antiarrhythmic drug therapy.
P F, Nestico +2 more
openaire +2 more sources
While controversy still exists as to the precise indications for the treatment of all forms of ventricular arrhythmia, advances in the number and, more importantly, type of antiarrhythmic drugs can provide the clinician with a rational basis for selecting antiarrhythmic drug therapy.
P F, Nestico +2 more
openaire +2 more sources
Medical Clinics of North America, 1988
The effective management of cardiac arrhythmias remains a major challenge in cardiovascular therapeutics. The management of arrhythmias encompasses a wide spectrum of supraventricular and ventricular tachyarrhythmias occurring in patients with various cardiac diagnoses and different degrees of myocardial dysfunction.
E L, Michelson, L S, Dreifus
openaire +2 more sources
The effective management of cardiac arrhythmias remains a major challenge in cardiovascular therapeutics. The management of arrhythmias encompasses a wide spectrum of supraventricular and ventricular tachyarrhythmias occurring in patients with various cardiac diagnoses and different degrees of myocardial dysfunction.
E L, Michelson, L S, Dreifus
openaire +2 more sources
The American Journal of Cardiology, 1989
Clinical failure of antiarrhythmic drugs often occurs in practice. Therefore, there is a need for new, effective and long-acting drugs with a wide therapeutic range and a low level of toxicity. Most new class I compounds block the fast sodium ion inward current of myocardial cells.
P, Jaillon, M, Drici
openaire +2 more sources
Clinical failure of antiarrhythmic drugs often occurs in practice. Therefore, there is a need for new, effective and long-acting drugs with a wide therapeutic range and a low level of toxicity. Most new class I compounds block the fast sodium ion inward current of myocardial cells.
P, Jaillon, M, Drici
openaire +2 more sources
The American Journal of Surgery, 1983
Great advances have been made in our understanding of cardiac arrhythmias and the effect of drugs on these arrhythmias. Several new types of antiarrhythmic drugs have been introduced. For example, encainide, flecainide, or lorcainide are new type I drugs that exert their major effects on depressing cardiac conduction.
M M, Scheinman, D S, Hess
openaire +2 more sources
Great advances have been made in our understanding of cardiac arrhythmias and the effect of drugs on these arrhythmias. Several new types of antiarrhythmic drugs have been introduced. For example, encainide, flecainide, or lorcainide are new type I drugs that exert their major effects on depressing cardiac conduction.
M M, Scheinman, D S, Hess
openaire +2 more sources
Annual Review of Medicine, 1987
The selection of an effective and well-tolerated antiarrhythmic drug requires a systematic approach. Two methods for evaluating drug effect are routinely used--noninvasive techniques involving monitoring and exercise testing, and an invasive approach utilizing electrophysiologic testing. Each method has strengths and weaknesses and they must be applied
openaire +2 more sources
The selection of an effective and well-tolerated antiarrhythmic drug requires a systematic approach. Two methods for evaluating drug effect are routinely used--noninvasive techniques involving monitoring and exercise testing, and an invasive approach utilizing electrophysiologic testing. Each method has strengths and weaknesses and they must be applied
openaire +2 more sources
The Journal of Clinical Pharmacology, 1989
Discussion sur l'efficacite d'un traitement antiarrythmique apres un infarctus du myocarde, sur la diminution de la mortalite chez les malades. Difficulte pratique d'effectuer un essai avec la flecainide et l'encainide, due a la mauvaise information des ...
openaire +2 more sources
Discussion sur l'efficacite d'un traitement antiarrythmique apres un infarctus du myocarde, sur la diminution de la mortalite chez les malades. Difficulte pratique d'effectuer un essai avec la flecainide et l'encainide, due a la mauvaise information des ...
openaire +2 more sources
The American Journal of Nursing, 1980
J L, Stanford, J M, Felner, D, Arensberg
openaire +2 more sources
J L, Stanford, J M, Felner, D, Arensberg
openaire +2 more sources